NasdaqGS - Nasdaq Real Time Price USD

Molecular Partners AG (MOLN)

Compare
7.27 -0.05 (-0.68%)
As of 10:04 AM EDT. Market Open.
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
6,726.00
7,038.00
189,556.00
9,330.00
9,344.00
--
Operating Expense
68,604.00
68,146.00
72,943.00
72,749.00
67,670.00
--
Operating Income
-61,878.00
-61,108.00
116,613.00
-63,419.00
-58,326.00
--
Net Non Operating Interest Income Expense
4,467.00
4,230.00
523.00
-457.00
63.00
--
Other Income Expense
-1,120.00
-5,106.00
717.00
92.00
-4,512.00
--
Pretax Income
-58,531.00
-61,984.00
117,853.00
-63,783.00
-62,775.00
--
Tax Provision
--
--
--
2.00
-11.00
--
Net Income Common Stockholders
-58,531.00
-61,984.00
117,853.00
-63,785.00
-62,764.00
--
Diluted NI Available to Com Stockholders
-58,531.00
-61,984.00
117,853.00
-63,785.00
-62,764.00
--
Basic EPS
-1.78
--
3.63
-2.06
-2.51
-1.69
Diluted EPS
-1.78
--
3.54
-2.06
-2.51
-1.69
Basic Average Shares
32,848.66
--
32,469.96
31,005.17
25,000.65
21,413.38
Diluted Average Shares
32,848.66
--
33,265.57
31,005.17
25,000.65
21,413.38
Total Operating Income as Reported
-61,878.00
-61,108.00
116,613.00
-63,418.00
-58,326.00
--
Total Expenses
68,604.00
68,146.00
72,943.00
72,749.00
67,670.00
--
Net Income from Continuing & Discontinued Operation
-58,531.00
-61,984.00
117,853.00
-63,785.00
-62,764.00
--
Normalized Income
-57,411.00
-56,878.00
117,136.00
-63,863.26
-58,252.79
--
Interest Income
4,514.00
4,279.00
1,142.00
99.00
367.00
--
Interest Expense
32.00
34.00
605.00
548.00
295.00
--
Net Interest Income
4,467.00
4,230.00
523.00
-457.00
63.00
--
EBIT
-58,499.00
-61,950.00
118,458.00
-63,235.00
-62,480.00
--
EBITDA
-56,084.00
-59,530.00
120,846.00
-60,670.00
-59,593.00
--
Reconciled Depreciation
2,415.00
2,420.00
2,388.00
2,565.00
2,887.00
--
Net Income from Continuing Operation Net Minority Interest
-58,531.00
-61,984.00
117,853.00
-63,785.00
-62,764.00
--
Total Unusual Items Excluding Goodwill
-1,120.00
-5,106.00
717.00
92.00
-4,512.00
--
Total Unusual Items
-1,120.00
-5,106.00
717.00
92.00
-4,512.00
--
Normalized EBITDA
-54,964.00
-54,424.00
120,129.00
-60,762.00
-55,081.00
--
Tax Rate for Calcs
--
--
--
0.00
0.00
--
Tax Effect of Unusual Items
--
--
--
13.74
-0.79
--
12/31/2019 - 6/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ZNTL Zentalis Pharmaceuticals, Inc.
4.0400
-2.88%
 
OBIO Orchestra BioMed Holdings, Inc.
7.58
+10.50%
 
EIGRQ Eiger BioPharmaceuticals, Inc.
12.60
-3.52%
 
SLDB Solid Biosciences Inc.
5.85
+2.63%
 
GRI GRI Bio, Inc.
1.7502
-4.29%
 
SABS SAB Biotherapeutics, Inc.
2.7800
-1.77%
 
NRBO NeuroBo Pharmaceuticals, Inc.
5.18
+7.30%
 
ICU SeaStar Medical Holding Corporation
7.29
-3.54%
 
CASI CASI Pharmaceuticals, Inc.
4.5499
+27.52%
 
SCNI Scinai Immunotherapeutics Ltd.
3.0200
-5.63%